MCFARLANE NEIL F. (President and CEO) sold 3.6% of their position (14.63K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $125.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/10/2026ACC: 0001681098-26-000004
DirectorOfficer· President and CEO
Since Feb 2026
-14.63K
Net shares
Net seller
$125.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
37.50K acquired · 52.13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+37.50K
Price / share
—
Trade value
—
% of position
10.3%
2/7/2026
364.35K→401.85K
Common Stock
Direct
Shares
−14.63K
Price / share
$8.56
Trade value
$125.19K
% of position
3.6%
2/9/2026
401.85K→387.23K
Total
Net shares
+22.88K
Net value
-$125.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/7/2026 | M · Option Exercise | +37.50K | — | — | 10.3% | 364.35K | 401.85K |
| Common Stock Direct | 2/9/2026 | S · Sale | −14.63K | $8.56 | $125.19K | 3.6% | 401.85K | 387.23K |
| Total | +22.88K | -$125.19K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
37.50K shares
Shares
−37.50K
Strike price
Held after
75K
Exercisable
—
2/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock37.50K shares | 2/7/2026 | M · Option Exercise | −37.50K | — | 75K |